Rchr
J-GLOBAL ID：201301006794853419
Update date: Mar. 22, 2024
Chuma Makoto
チュウマ マコト | Chuma Makoto
Homepage URL (1)：
http://kaken.nii.ac.jp/d/r/30360910.ja.html
Research field (1)：
Gastroenterology
Research keywords (2)：
肝臓病学
, 肝癌
Research theme for competitive and other funds (4)：
- 2021 - 2024 Examination of immunotherapy improvement through CD8+ T cell induction of refractory hepatocellular carcinoma and, construction of biomarkers.
- 2014 - 2017 Investigation of the HSF1 signaling pathway as the molecular targeted therapies for hepatocellular carcinoma.
- 2008 - 2010 The development of a quantitative assay of a single-nucleotide mutant of drug-resistant hepatitis virus.
- 2008 - 2010 Molecular Screening by Microarray analysis for Hepatocarcinogenesis.
Papers (101)：
-
Hidenori Toyoda, Toshifumi Tada, Haruki Uojima, Akito Nozaki, Makoto Chuma, Koichi Takaguchi, Atsushi Hiraoka, Hiroshi Abe, Ei Itobayashi, Kentaro Matsuura, et al. Comparison of six hepatocellular carcinoma prediction models in Japanese patients after sustained virologic response undergoing rigorous surveillance for hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 2024
-
Angela Chau, Ming-Lun Yeh, Pei-Chien Tsai, Daniel Q Huang, Sung Eun Kim, Huy Trinh, Eileen L Yoon, Hyunwoo Oh, Jae Yoon Jeong, Sang Bong Ahn, et al. Sex Differences in Treatment Response to Nucleos(t)ide Therapy in Chronic Hepatitis B: A Multicenter Longitudinal Study. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2023
-
Yu Jun Wong, Sally Tran, Chung-Feng Huang, Yao-Chun Hsu, Carmen Preda, Hidenori Toyoda, Joanne Liu, Dae Won Jun, Charles Landis, Daniel Q. Huang, et al. Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C study. Hepatology International. 2023
-
Taito Fukushima, Manabu Morimoto, Satoshi Kobayashi, Makoto Ueno, Haruki Uojima, Hisashi Hidaka, Chika Kusano, Makoto Chuma, Kazushi Numata, Kota Tsuruya, et al. Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab. The oncologist. 2023
-
Masanori Atsukawa, Akihito Tsubota, Chisa Kondo, Kaori-Shioda Koyano, Toru Ishikawa, Hidenori Toyoda, Koichi Takaguchi, Tsunamasa Watanabe, Kentaro Matsuura, Chikara Ogawa, et al. Risk factors for portopulmonary hypertension in patients with cirrhosis: a prospective, multicenter study. Hepatology international. 2022. 17. 1. 139-149
ｍore...
MISC (31)：
-
Hidenori Toyoda, Huy N. Trinh, Jennifer Leong, Masanori Atsukawa, Tsunamasa Watanabe, Makoto Chuma, Joanne Liu, Keisuke Yokohama, Hansen Dang, Mayumi Maeda, et al. VIROLOGIC, BIOCHEMICAL, AND RENAL OUTCOMES OF TREATMENT-NAIVE PATIENTS WITH SEQUENTIAL THERAPY FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TENOFOVIR ALAFENAMIDE (TAF) IN ROUTINE PRACTICE. HEPATOLOGY. 2020. 72. 498A-499A
-
Shin Maeda, Yohko Hikiba, Makoto Sugimori, Yoshihiro Kaneta, Soichiro Sue, Hiroaki Kaneko, Tomohiko Sasaki, Kuniyasu Irie, Masaaki Kondo, Makoto Chuma. ROLE OF APOPTOSIS SIGNAL-REGULATING KINASE 1 IN NAFL-ASSOCIATED HEPATOCARCINOGENESIS IN MICE. GASTROENTEROLOGY. 2019. 156. 6. S1296-S1297
-
佃 曜子, 伊藤 淳, 常松 聖司, 佐藤 史幸, 寺下 勝巳, 中井 正人, 堀本 啓大, 荘 拓也, 須田 剛生, 夏井坂 光輝, et al. L-カルニチンのC型肝炎ウイルス増殖抑制効果に関する研究. 日本消化器病学会雑誌. 2014. 111. 臨増大会. A916-A916
-
中馬 誠, 山本 義也, 小川 浩司, 荘 拓也, 佃 曜子, 目黒 高志, 永坂 敦, 中村 路夫, 工藤 峰生, 武藤 修一, et al. 肝がん治療戦略のUp to Date 進行肝細胞癌に対する分子標的治療、肝動注療法の位置づけと今後の展開. 日本癌治療学会誌. 2014. 49. 3. 790-790
-
荘 拓也, 中馬 誠, 常松 聖司, 佐藤 史幸, 佃 曜子, 寺下 勝巳, 中井 正人, 堀本 啓大, 須田 剛生, 夏井坂 光輝, et al. 当科におけるHCV/HIV重複感染症の現状と抗HCV療法. 肝臓. 2014. 55. Suppl.1. A213-A213
ｍore...
Education (1)：
- - 1993 Hokkaido University School of Medicine
Professional career (1)：
Work history (1)：
- 2012/04 - 2014/03 Hokkaido University Hospital Departments of Gastroenterology and Hepatology lecturer
Committee career (2)：
- 2010 - 現在 日本消化器病学会 評議員
- 2014 - 2018 日本肝臓学会 評議員
Return to Previous Page
